ARTICLE | Financial News
scPharmaceuticals raises $45.6M in series B
January 5, 2017 1:35 AM UTC
Drug delivery company scPharmaceuticals Inc. (Lexington, Mass.) raised $45.6 million in a series B round co-led by OrbiMed and Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA). Existing investors 5AM Ventures and Lundbeckfond Ventures also participated...